EVOLOCUMAB subcutaneous injection (Repatha®)
Clinical Indication
Primary hypercholesterolaemia or mixed dyslipidaemia
Comments
In line with NICE TA 394
Local guidance
Moved from black traffic light end Sept 2016
Date of classification
September 2016
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.